Vinod Balachandran, MD, General Surgery, New York, NY, Memorial Sloan-Kettering Cancer Center

VinodBalachandranMDFACS

General Surgery New York, NY

Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)

Assistant Attending Surgeon

Dr. Balachandran is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Balachandran's full profile

Already have an account?

Summary

  • I am a surgical oncologist who specializes in treating people with both benign and cancerous diseases of the pancreas, bile duct, gallbladder, and liver.
  • Vinod P. Balachandran

    I am a surgical oncologist who specializes in treating people with both benign and cancerous diseases of the pancreas, bile duct, gallbladder, and liver. Plus a

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterFELLOWSHIP
  • New York Presbyterian Hospital - Cornell Campus
    New York Presbyterian Hospital - Cornell CampusRESIDENCY
  • Stony Brook University School of Medicine
    Stony Brook University School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2009 - 2021
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Press Mentions

  • Memorial Sloan Kettering Awards and Appointments
    Memorial Sloan Kettering Awards and AppointmentsAugust 18, 2020 10:52
  • The Pershing Square Sohn Cancer Research Alliance Awards $4.2M to Seven Rising Leaders in Cancer Research
    The Pershing Square Sohn Cancer Research Alliance Awards $4.2M to Seven Rising Leaders in Cancer ResearchJuly 30, 2020 09:37
  • ILC2s Sensitise Pancreatic Tumours to PD-1 Checkpoint Inhibitors in Mice
    ILC2s Sensitise Pancreatic Tumours to PD-1 Checkpoint Inhibitors in MiceFebruary 27, 2020 01:14
  • Join now to see all

Grant Support

  • Stand Up to Cancer Convergence AwardStand Up to Cancer Pancreas Cancer CollectivePresent
  • Damon Runyon Clinical Investigator AwardDamon Runyon FoundationPresent
  • U01 Biden Cancer Moonshot AwardNational Cancer InstitutePresent
  • NIH/K12 Paul Calabresi Career Development AwardNational Institutes of HealthPresent

Professional Memberships

Other Languages

  • Chinese (Mandarin), Hindi

Hospital Affiliations